Marcelo Bravo, chief technology officer, said: "Securing regulatory approval for our initial in human clinical trial has achieved another important milestone in the development of safer non steroidal anti inflammatory drugs via our OXPZero technology. We are extremely excited about reaching this milestone as this is the first product of its kind featuring the technology.
of medicines, including ibuprofen and aspirin.
It has also carried out two successful rounds of funding and has received Nike Hyperdunk 2017 Release Date
of products that will include gastrointestinal safe formulations that address the enormous market for non steroidal anti inflammatory drugs. These are among the most widely used classes Hypervenom Wolf Grey
Oxford Pharmascience, based in Chellaston, has been shortlisted for the title of Best Health Care Plc at the 2014 UK Stock Market Awards, having seen its share price increase by 70% and revenues double over the past year.
More than 30 million people use these drugs every day and the market for the products is worth billions. However, regular use has been shown to cause gastrointestinal side effects, including ulcers and bleeding that can, in some cases, be fatal.
approval for its latest clinical trial application from the UK Medicines and Healthcare Products Regulatory Agency and the Ethics Review Committee.
"It has a dual mode of action to significantly reduce gastrointestinal side effects and will offer a new treatment option for patients taking these drugs on a long term basis."
A DERBY pharmaceutical company has been nominated for a national award and is starting clinical trials for a product that could be worth millions of pounds.
Derby drugs company is nominated for award as it begins clinical trials
The company has already picked up industry Hypervenom Qs accolades. In November, it was awarded the Innovation Award by Ach Laborat its pharmaceutical partner in Brazil, which markets and sells the Derby firm's calcium chews. The previous December, it was featured in Lux Research's Top Emerging Technology Companies list.
Oxford Pharmascience is working on its next generation Nike Hyperdunk 2017 Review
The pilot study involves a product that delivers 400mg of ibuprofen while reducing the risk of stomach problems and other side effects associated with taking some anti inflammatory painkilling drugs. Oxford Pharmascience specialises in technology that makes this class of medicines safer and easier to take.
Nominees for the awards were selected by judges looking at share price performance, commercial success and balance sheets as well as the quality of the management team.
Nike Kobe Xi Elite